九州通 (600998)
Jointown Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data available
Company NameJiuzhou Tong Pharmaceutical Group Co., Ltd.
Listing Date2010-11-02
Issue Price13RMB
Registered Capital504247.023410k RMB
Legal RepresentativeLiu Changyun
Registered AddressNo. 5 Longxing West Street, Hanyang District, Wuhan City, Hubei Province
IndustryPharmaceutical Commerce
Main BusinessWholesale of pharmaceuticals, medical devices, Chinese medicinal materials and prepared slices, food, health products, etc.; retail chain; pharmaceutical production and R&D; and value-added services.
Company ProfileJiuzhou Tong Group is a Sino-foreign joint stock company whose core businesses include wholesale and retail chain of pharmaceuticals, medical devices, and other products, pharmaceutical production and R&D, and related value-added services. It is one of the three largest pharmaceutical commercial circulation enterprises in China and one of only two companies in the pharmaceutical commercial sector with a nationwide network.
Stock Details
1. Key Indicators
- Total Shares(W): 504247.02
- Circulating A-Shares(W): 504247.02
- Earnings Per Share(RMB): 0.39
- Net Assets Per Share(RMB): 5.25
- Operating Revenue(W RMB): 11932657.17
- Total Profit(W RMB): 269883.61
- **Net Profit Attributable to Parent(W RMB) **: 197544.98
- Net Profit Growth Rate(%): 16.46
- Weighted Return on Equity(%): 7.30
- Operating Cash Flow Per Share(RMB): -0.46
- Undistributed Profit Per Share(RMB): 2.97
- Capital Reserve Per Share(RMB): 1.02
2. Main Business
The main business covers:
- Wholesale of pharmaceuticals, medical devices and other products
- Retail chain operations
- Pharmaceutical production, research and development, and related value-added services
3. Company Basic Information
- Company Name: Jiuzhoutong Pharmaceutical Group Co., Ltd.
- Listing Date: 2010-11-02
- Industry: Pharmaceutical Commerce
- Address: No. 5 Longxing West Street, Hanyang District, Wuhan City, Hubei Province
- Website: https://www.jztey.com/
- Company Profile: Jiuzhoutong Pharmaceutical Group Co., Ltd. was established as a joint stock company through the transformation of Jiuzhoutong Group Co., Ltd., approved by Hubei Provincial Department of Commerce document E Shang Zi [2008] No. 133. Based on the audited net assets of Jiuzhoutong Group Co., Ltd. as of June 30, 2008, which amounted to 1,170,515,819.56 yuan, the company was converted at a 1:1 ratio into 1,170,515,819 shares with a par value of 1.00 yuan per share, with the remaining net assets of 0.56 yuan recorded as capital reserve. On November 28, 2008, the company obtained its business license with registration number 420000400000103, with registered capital of 1,170.515819 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Hongkang Industrial Investment Co., Ltd. | Corporate Legal Person | 108832.68 | 21.58 |
| 2 | Shilong International Group (Hong Kong) Co., Ltd. | Corporate Legal Person | 57557.59 | 11.41 |
| 3 | Chuchang Investment Group Co., Ltd. | Corporate Legal Person | 36252.60 | 7.19 |
| 4 | Zhongshan Guangyin Investment Co., Ltd. | Corporate Legal Person | 33535.73 | 6.65 |
| 5 | Beijing Dianjin Investment Co., Ltd. | Corporate Legal Person | 27653.14 | 5.48 |
| 6 | China Cinda Asset Management Co., Ltd. | Corporate Legal Person | 25212.33 | 5.00 |
| 7 | National Social Security Fund 604 Portfolio | Social Security Fund | 7083.60 | 1.40 |
| 8 | Great Wall Guotai (Zhoushan) Industrial M&A Restructuring Fund Partnership (Limited Partnership) | Corporate Legal Person | 6847.18 | 1.36 |
| 9 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 6263.92 | 1.24 |
| 10 | China Merchants Social Responsibility Mixed Securities Investment Fund Class A | Fund | 371.19 | 0.07 |
5. Concept Sectors
- Venture Capital Concept
- Photovoltaic
- Intelligent Machines
- Gene Concept
- Intelligent Healthcare
- Artificial Intelligence
- Medical Aesthetics Concept
- Green Power
- Cold Chain Logistics
- Innovative Drugs
- AI Agents
- DeepSeek
- AI Healthcare
- Margin Trading & Securities Lending
- Low P/E Ratio
- Below Net Asset Value
- Investment in New Shares
- MSCI Constituent
- Social Security Fund New Positions
- High Accounts Receivable
- SSE 380
- Mid Cap Value
- SZSE Value Index
Remarks
- Data update date: 2025-11-02
- Data source: Public market information
